Full Text
Budget Impact Analysis of Obinutuzumab And Ibrutinib In Patients With Chronic Lymphocytic Leukemia In Russia

Abstract

Authors

EV Derkach OY Rebrova VK Fedyaeva

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×